Empirical Formula of Trifluperidol hydrochloride (CAS NO.2062-77-3): C22H24ClF4NO2
Molecular Weight: 445.8781 g/mol
Flash Point: 265.8 °C
Enthalpy of Vaporization: 82.95 kJ/mol
Boiling Point: 515.9 °C at 760 mmHg
Vapour Pressure: 1.8E-11 mmHg at 25 °C
Structure of Trifluperidol hydrochloride (CAS NO.2062-77-3):
IUPAC Name: 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one hydrochloride
Canonical SMILES: C1CN(CCC1(C2=CC(=CC=C2)C(F)(F)F)O)CCCC(=O)C3=CC=C(C=C3)F.Cl
InChI: InChI=1S/C22H23F4NO2.ClH/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26;/h1,3-4,6-9,15,29H,2,5,10-14H2;1H
InChIKey: VYGQXRZAHIZHQV-UHFFFAOYSA-N
1. | orl-rat LDLo:75 mg/kg | THERAP Therapie. 17 (1962),1053. | ||
2. | scu-rat LD50:70 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 11 (1961),932. | ||
3. | ivn-rat LD50:14 mg/kg | 27ZQAG Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,194. | ||
4. | orl-mus LD50:99 mg/kg | THERAP Therapie. 17 (1962),1053. | ||
5. | scu-mus LD50:80 mg/kg | 27ZQAG Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,194. | ||
6. | ivn-mus LD50:17,400 µg/kg | THERAP Therapie. 17 (1962),1053. |
Poison by subcutaneous, intravenous, and ingestion routes. When heated to decomposition Trifluperidol hydrochloride (CAS NO.2062-77-3) emits very toxic fumes of F−, NOx, and HCl. See also FLUORIDES.
Trifluperidol hydrochloride , its cas register number is 2062-77-3. It also can be called Trisedil hydrochloride ; 4'-Fluoro-4-(4-hydroxy-4-trifluoromethylphenylpiperidino)butyrophenone hydrochloride ; and 1-Butanone, 1-(4-fluorophenyl)-4-(4-hydroxy-4-(3-(trifluoromethyl)phenyl)-1-piperidinyl)-, hydrochloride (9CI) .
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View